Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.032 AUD 0.00(0%)
Last update at 2026-11-10T23:00:00Z
Market Cap
23.26M

Momentum Score

…

Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, X-ray, and ultrasound images. Its healthcare data solutions include ENDEX, a platform that uses AI to standardize new and historical medical image data descriptions; ENCOG, an AI enabled data anonymization solution designed to de-identify protected health information from medical imaging data; and Migratek, an AI-enabled data migration solution, as well as routing services. The company provides its solutions to radiologists, IT professionals, executives, and researchers; and training services to PACS administrators, IT supervisors, system administrators, radiologists, and technologists. The company was formerly known as You Partners, Inc. Enlitic, Inc. was incorporated in 2014 and is based in Loveland, Colorado.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.03
Low
0.03
High
52 Week Price Range
0.03
Low
0.45
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Enlitic Inc is an Australia-listed company developing artificial intelligence for medical imaging to assist clinicians with detection and workflow prioritization. Long-term growth drivers include rising AI adoption in healthcare, increasing diagnostic demand, and software scalability that may appeal to investors seeking exposure to clinical AI.

Key risks are the need for robust clinical evidence and regulatory clearance, strong competition from established medical-imaging vendors and other AI firms, and funding and commercialization challenges typical of small health-technology companies.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.03
Dividend Yield
-
Revenue TTM
3.60M
Revenue Per Share
0.04
Gross Profit TTM
-7.27M
Debt / Equity
-
ROE
-349.07%
Net Debt
-
ROCE
-327.47%
Diluted EPS TTM
-0.28

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Income before tax -13.34M -15.25M -15.55M -25.04M
Net income -13.37M -15.24M -15.55M -25.04M
Selling general administrative 12.17M 15.50M 14.39M 16.13M
Gross profit 3.80M 1.08M 0.50M -
Reconciled depreciation 0.67M 0.16M 0.40M -
Operating income -13.35M -15.74M -15.50M -17.56M
Interest expense 0.04M 0.00M 0.05M -
Tax provision 0.03M -0.01M 0.00M 0.00M
Interest income 0.04M 0.01M 0.06M 7.48M
Net interest income -0.00M 0.12M 0.01M -
Total revenue 3.80M 1.22M 0.56M 0.90M
Total other income expense net 0.01M 0.52M -0.05M -
Net income from continuing ops -13.37M -15.24M -15.55M -
Net income applicable to common shares - -15.24M -15.55M -25.04M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total assets 8.96M 14.20M 11.57M 3.10M
Intangible assets 2.90M 0.02M 0.01M 0.01M
Other current assets 0.08M 0.15M 0.01M -
Total liab 4.88M 3.17M 0.63M 30.76M
Total stockholder equity 4.08M 11.03M 10.94M -27.66M
Other current liab 2.02M 1.09M - -
Common stock - - - 58.76M
Capital stock 134.50M 128.17M 112.75M -
Retained earnings -133.74M -120.37M -105.13M -86.64M
Good will 1.84M 4.33M - -
Cash 2.57M 7.16M 11.09M 2.22M
Total current liabilities 4.88M 2.90M 0.63M 30.76M
Short term debt - - - 23.93M
Short long term debt 0.89M - - -
Other stockholder equity - - - 0.21M
Property plant equipment - - - 0.51M
Total current assets 4.08M 8.69M 11.44M 2.57M
Net receivables 0.84M 0.67M 0.07M 0.04M
Long term debt - 0.20M - -
Accounts payable 0.46M 1.18M 0.26M -
Non currrent assets other - 0.00M - -
Non current assets total 4.87M 5.51M 0.13M -
Capital lease obligations 0.01M 0.11M - -
Long term debt total - - - 0.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Investments - -3.12M 0.00M -
Total cashflows from investing activities - -3.12M - -
Net borrowings 1.49M - - -
Total cash from financing activities 7.71M 14.45M 23.72M -
Net income -13.37M -15.24M -15.55M -25.04M
Change in cash -4.06M -3.93M 8.84M -
Begin period cash flow 7.16M 11.09M 2.22M -
End period cash flow 2.57M 7.16M 11.09M 2.22M
Total cash from operating activities - -15.17M - -
Issuance of capital stock 6.92M 15.61M 25.38M -
Other cashflows from investing activities - -0.00M - -
Sale purchase of stock -0.59M -1.14M -1.36M -
Other cashflows from financing activities - -0.02M - -
Capital expenditures 0.01M 0.02M 0.00M 0.00M
Change in working capital - 0.12M - -
Free cash flow -11.80M -15.19M -14.88M -

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ENL
Enlitic Inc
-
-%
0.03 - - 6.46 3.88 3.73 -2.37
PME
Pro Medicus Ltd
-4.52
2.18%
202.79 81.98 106.38 83.13 43.70 74.38 95.34
4DX
4DMEDICAL Ltd
-0.06
2.53%
2.31 - - 205.57 8.53 170.03 -7.29
CGS
Cogstate Ltd
0.12
3.30%
3.76 33.80 27.86 9.59 6.95 6.35 19.27
AYA
ARTRYA Ltd
-0.14
3.91%
3.44 - - 20505.14 7.00 16927.51 0.33

Profile*

Enlitic Inc

Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, X-ray, and ultrasound images. Its healthcare data solutions include ENDEX, a platform that uses AI to standardize new and historical medical image data descriptions; ENCOG, an AI enabled data anonymization solution designed to de-identify protected health information from medical imaging data; and Migratek, an AI-enabled data migration solution, as well as routing services. The company provides its solutions to radiologists, IT professionals, executives, and researchers; and training services to PACS administrators, IT supervisors, system administrators, radiologists, and technologists. The company was formerly known as You Partners, Inc. Enlitic, Inc. was incorporated in 2014 and is based in Loveland, Colorado.

1635 Foxtrail Drive, Loveland, CO, United States, 80538

877-365-4842

Name Title Year Born
Mr. Lawrence B. Gozlan B.Sc., B.Sc.(Hons) Executive Chairman of the Board 1979
Mr. Michael Karlgerhard Sistenich B.Sc, M.Sc., MSc CEO & Director 1975
Mr. Kevin Lyman Founder & Chief Science Officer NA
Mr. Darren Scotti Chief Financial Officer NA
Mr. John Marshall Chief Operating Officer NA
Mr. Dan Kozimor Chief Technology Officer NA
Ms. Patty O'Brien Chief Compliance Officer NA
Mr. Dave Wilson Vice President of Marketing & Communications NA
Mr. Scott Stanton Vice President of Sales Operations NA
Mr. Ryan Lennartson Vice President of People Operations NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…